Tidmarsh, an adjunct professor at Stanford’s medical school, brings decades of industry experience to the table. Serving as ...

FDA issues a complete response letter for glofitamab's second-line DLBCL indication, highlighting ongoing scrutiny in ...

Troculeucel, a cryopreserved, autologous enhanced natural killer cell therapy, has demonstrated preliminary clinical benefit without any drug-related adverse events in two Phase I clinical trials in ...

"FDA approves Dymicron’s study of cervical artificial disc" was originally created and published by Medical Device Network, a ...

"Following rigorous evaluation of the data, FDA decided that a marketing granted order for the Juul System was 'appropriate for the protection of public health' — the standard required by ...

iTolerance, Inc. Appoints Former FDA Senior Executive Wayne Pines to the Board of Directors ACCESS Newswire. Updated June 25, 2025 ... Chairman of the iTolerance Board of Directors.

MIAMI, FL / ACCESS Newswire / June 25, 2025 / iTolerance, Inc. ("iTolerance" or the "Company"), an early-stage privately-held biotechnology company focused on the development of innovative ...